(Q37872562)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11850163%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11850163%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11850163%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

A Speciale

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11850163%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

R Musumeci

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11850163%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

I Milazzo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11850163%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

F Caccamo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11850163%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G Nicoletti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11850163%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

language of work or name

1 reference

1 February 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11850163%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Antimicrobial Agents

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11850163%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11850163%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11850163%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

111-118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11850163%20AND%20SRC:MED&resulttype=core&format=json

The future of the quinolones

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900486-1

7 January 2021

Fluoroquinolone antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900486-1

7 January 2021

New quinolones and gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900486-1

7 January 2021

In vitro activity of BAY 12-8039, a new 8-methoxyquinolone.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900486-1

7 January 2021

Comparative susceptibility to penicillin and quinolones of 1385 Streptococcus pneumoniae isolates. Austrian Bacterial Surveillance Network.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900486-1

7 January 2021

In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900486-1

7 January 2021

The in-vitro activity of CP 99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900486-1

7 January 2021

In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900486-1

7 January 2021

In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in huma

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900486-1

7 January 2021

Susceptibility of Chlamydia trachomatis to trovafloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900486-1

7 January 2021

10.1016/S0924-8579(01)00486-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11850163%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference